Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Effects of geniposide on hepatocytes undergoing epithelial-mesenchymal transition in hepatic fibrosis by targeting TGF beta/Smad and ERK-MAPK signaling pathways

Authors
Park, Ji-HyunYoon, JaewooLee, Ki YongPark, Byoungduck
Issue Date
6월-2015
Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
Keywords
Transforming growth factor; Fibrosis; Type-I collagen; Hepatocyte; Geniposide
Citation
BIOCHIMIE, v.113, pp.26 - 34
Indexed
SCIE
SCOPUS
Journal Title
BIOCHIMIE
Volume
113
Start Page
26
End Page
34
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/93445
DOI
10.1016/j.biochi.2015.03.015
ISSN
0300-9084
Abstract
Liver fibrosis results from increased deposition of type-I collagen within the hepatic extracellular space and constitutes a common cardinal signature in all forms of liver injury, regardless of etiology. Transforming growth factor beta 1 (TGF-beta 1) plays a crucial role in the pathogenesis of liver fibrosis. Geniposide is recognized as being useful against hyperlipidemia and fatty liver. However, its cellular mechanism and anti-fibrotic effect in TGF-beta 1-induced hepatocytes have not been explored. In the present study, we investigated its anti-epithelial-mesenchymal transition (EMT) mechanism by examining the effect of geniposide on TGF-beta 1-induced hepatocytes. The effect of geniposide on TGF-beta 1-induced AML12 cells was assessed using Western blotting, quantitative real-time PCR, immunofluorescence staining and DNA binding activity. We found that geniposide significantly inhibited TGF-beta 1 -induced mRNA and protein expression of type-I collagen. Cells treated concurrently with TGF-beta 1 and geniposide retained high levels of localized E-cadherin expression with no increase in vimentin. Treatment with geniposide almost completely blocked the phosphorylation of Smad2/3, extracellular signal-regulated kinase (ERK) and Akt in AML12 cells. Taken together, these results suggest that geniposide may suppress TGF-beta 1 -induced EMT in hepatic fibrosis by inhibiting the TGF beta/Smad and ERK-mitogen-activated protein kinase (MAPK) signaling pathways. Our results may help researchers better understand the pathogenesis of liver fibrosis so they can develop novel therapeutic strategies for treatment of liver diseases. (C) 2015 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM). All rights reserved.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Pharmacy > Department of Pharmaceutical Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Lee, Ki Yong photo

Lee, Ki Yong
약학대학 (약학과)
Read more

Altmetrics

Total Views & Downloads

BROWSE